X0202 SCHEDULE 13G 0001048462 XXXXXXXX LIVE Ordinary Shares, no par value 04/08/2026 0001898643 MOBILICOM LIMITED Q6297L120 1 Rakefet Street Shoham L3 6083705 Rule 13d-1(c) Wexford Capital LP DE 0.00 666376.00 0.00 666376.00 666376.00 N 5.27 PN Wexford GP LLC DE 0.00 666376.00 0.00 666376.00 666376.00 N 5.27 OO Charles E. Davidson X1 0.00 666376.00 0.00 666376.00 666376.00 N 5.27 IN Joseph M. Jacobs X1 0.00 666376.00 0.00 666376.00 666376.00 N 5.27 IN MOBILICOM LIMITED 1 Rakefet Street, Shoham, Israel 6083705 Wexford Capital LP ("Wexford Capital"), Wexford GP LLC ("Wexford GP"), Charles E. Davidson ("Davidson") and Joseph M. Jacobs ("Jacobs", and together with Wexford Capital, Wexford GP and Davidson, the "Reporting Persons") are hereby jointly filing this Schedule 13G because such Reporting Persons may be deemed to beneficially own the same securities named in Item 1 by certain Wexford Funds (as defined below) due to certain affiliations among the Reporting Persons. In accordance with Rule 13d-1(k)(1)(iii) promulgated pursuant to the Securities Exchange Act of 1934, as amended, the Reporting Persons have executed a written agreement relating to the joint filing of this Schedule 13G (the "Joint Filing Agreement"), a copy of which is annexed hereto as Exhibit 99.1. The address of the principal business office of the Reporting Persons is c/o Wexford Capital LP, 777 South Flagler Drive, Suite 602 East, West Palm Beach, FL 33401. Each of Wexford Capital and Wexford GP are formed in Delaware. Each of Davidson and Jacobs are United States citizens. Y The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Wexford Capital may, by reason of its status as (i) sub-advisor of each of Wexford Spectrum Trading Limited ("WST") and Wexford Catalyst Trading Limited ("WCT") and (ii) investment manager of Wexford Focused Trading Limited ("WFT", and together with WST and WCT, the "Wexford Funds"), be deemed to own beneficially the securities held by the Wexford Funds. Wexford GP may, as the General Partner of Wexford Capital, be deemed to own beneficially the securities held by the Wexford Funds. Each of Davidson and Jacobs may, by reason of his status as a controlling person of Wexford GP, be deemed to own beneficially the securities held by the Wexford Funds. Each of Wexford Capital, Wexford GP, Davidson and Jacobs share the power to vote and to dispose of the securities beneficially owned by the Wexford Funds. Each of Wexford Capital, Wexford GP, Davidson and Jacobs disclaim beneficial ownership of the securities held by the Wexford Funds and this report shall not be deemed as an admission that they are the beneficial owners of such securities except, in the case of Davidson and Jacobs, to the extent of their respective pecuniary interests therein. The information required by Item 4(b) is set forth in Row 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information in Row 11 is calculated on the basis of 12,633,371 Ordinary Shares issued and outstanding as of March 22, 2026, as reported by the Issuer in the Form 20-F filed by the Issuer with the Securities and Exchange Commission on March 23, 2026. The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Y N The Wexford Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares hares of reported herein. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Wexford Capital LP /s/ Mark E. Ahern 04/14/2026 Wexford GP LLC /s/ Mark E. Ahern 04/14/2026 Charles E. Davidson /s/ Charles E. Davidson 04/14/2026 Joseph M. Jacobs /s/ Joseph M. Jacobs 04/14/2026